This application is a competing renewal of R01 CA84360 previously entitled """"""""The Metalloproteinase Matrilysin in Breast Cancer"""""""". The title is changed to """"""""Tumor and Stromal MMPs in Breast Cancer"""""""" to reflect an expansion of the focus of the application from the role of MMP-7 (matrilysin) in early stage breast cancer to the role of both tumor and stromal MMP family members in the processes of breast metastasis to lung and bone. The clinical experience with MMP inhibitors over the past few years indicates these agents are ineffective in controlling the progression of advanced stage cancer. However, an NCI-sponsored workshop recently concluded that MMP inhibition represents a therapeutic opportunity for minimal residual disease and bone metastases. Thus, we have changed the focus of this grant to concentrate on the clinically relevant problems of breast cancer metastasis to lung and bone with the goal of increasing our understanding of the MMP contribution to these processes with preventive or therapeutic endpoints in mind. Using an MMTV-polyoma middle T antigen (PyVT) transgenic mouse system, we demonstrated that the lack of MMP-7 and MMP-9 has no impact on the development of primary mammary tumors, but MMP-9 deficiency reduces the development of lung metastases. Tumor-associated MMPs can be either tumor or stromal in origin. We have determined that host-derived MMP-9 is required for efficient establishment of lung metastases following tail vein injection of lung carcinoma cells. Our working hypothesis is that MMPs contribute to breast cancer metastasis to lung and bone by mediating tumor/stroma interactions. We propose to examine the contribution of tumor and stromal MMPs to: 1) the dormancy, development, and growth of breast metastases in lung, and 2) the growth and lytic activity of breast metastases in bone using syngeneic mouse model systems of MMTV-PyVT-derived mammary tumor cells placed in the lung or bone microenvironment. The molecular mechanisms underlying the effect of tumor or stromal MMPs will be probed using organotypic co-culture models of lung and bone and both candidate and unbiased proteomic approaches to identify relevant MMP substrates. These studies will provide guidance for the application of synthetic MMP inhibitors for the prevention and treatment of breast cancer metastasis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA084360-08
Application #
7162065
Study Section
Special Emphasis Panel (ZRG1-TME (01))
Program Officer
Mohla, Suresh
Project Start
2000-01-19
Project End
2009-12-31
Budget Start
2007-01-01
Budget End
2007-12-31
Support Year
8
Fiscal Year
2007
Total Cost
$453,591
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Shay, Gemma; Lynch, Conor C; Fingleton, Barbara (2015) Moving targets: Emerging roles for MMPs in cancer progression and metastasis. Matrix Biol 44-46:200-6
Bates, Andreia L; Pickup, Michael W; Hallett, Miranda A et al. (2015) Stromal matrix metalloproteinase 2 regulates collagen expression and promotes the outgrowth of experimental metastases. J Pathol 235:773-83
auf dem Keller, Ulrich; Prudova, Anna; Eckhard, Ulrich et al. (2013) Systems-level analysis of proteolytic events in increased vascular permeability and complement activation in skin inflammation. Sci Signal 6:rs2
Thiolloy, Sophie; Edwards, James R; Fingleton, Barbara et al. (2012) An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment. PLoS One 7:e29862
Martin, Michelle D; Kremers, Gert-Jan; Short, Kurt W et al. (2010) Rapid extravasation and establishment of breast cancer micrometastases in the liver microenvironment. Mol Cancer Res 8:1319-27
McIntyre, J Oliver; Scherer, Randy L; Matrisian, Lynn M (2010) Near-infrared optical proteolytic beacons for in vivo imaging of matrix metalloproteinase activity. Methods Mol Biol 622:279-304
Thiolloy, Sophie; Halpern, Jennifer; Holt, Ginger E et al. (2009) Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis. Cancer Res 69:6747-55
McIntyre, J Oliver; Matrisian, Lynn M (2009) Optical proteolytic beacons for in vivo detection of matrix metalloproteinase activity. Methods Mol Biol 539:155-74
Martin, Michelle D; Carter, Kathy J; Jean-Philippe, Sharon R et al. (2008) Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background. Cancer Res 68:6251-9
Scherer, Randy L; McIntyre, J Oliver; Matrisian, Lynn M (2008) Imaging matrix metalloproteinases in cancer. Cancer Metastasis Rev 27:679-90

Showing the most recent 10 out of 17 publications